Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy

XU  Jian-ming; LIU  Jian-hua

doi:10.3969/j.issn.1671-5144.2011.02.014

XU Jian-ming, LIU Jian-hua. Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy[J]. Journal of Evidence-Based Medicine, 2011, 11(2): 91-93. DOI: 10.3969/j.issn.1671-5144.2011.02.014

Citation:

XU Jian-ming, LIU Jian-hua. Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy[J]. Journal of Evidence-Based Medicine, 2011, 11(2): 91-93. DOI: 10.3969/j.issn.1671-5144.2011.02.014

Citation:

XU Jian-ming, LIU Jian-hua. Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy[J]. Journal of Evidence-Based Medicine, 2011, 11(2): 91-93. DOI: 10.3969/j.issn.1671-5144.2011.02.014

Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy

Graphical Abstract

Abstract

FullText(HTML)

References (3)

Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy

Catalog

Export File

Citation

Format

Content